Transfusion-associated graft-versus-host disease (TA-GVHD), a rare complication of blood transfusion, is usually fatal. Patients in certain clinical categories, including bone marrow transplants, solid tumors and acquired T cell defects, are at greater risk of developing TA-GVHD. TA-GVHD can be prevented by the irradiation of cellular blood products prior to transfusion.
RAD-SURE® blood irradiation indicators provide positive, visual verification of irradiation. When attached to blood products, RAD-SURE® Type XR 15 Gy, Type XR 25 Gy, Type 15 Gy and Type 25 Gy indicators show whether the blood products have been irradiated or not.